The effect of selective phosphodiesterase inhibitors on plasma insulin concentrations and insulin secretion in vitro in the rat.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  European Journal of Pharmacology

• Publication date

  1997-04-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-2999(97)00076-9PMID 9145777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo.

  1996cited by this paper
• Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family.

  1996cited by this paper
• A Novel Insulin Secretagogue Is a Phosphodiesterase Inhibitor

  1995cited by this paper
• Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion.

  1995cited by this paper
• Metabolic and hormone-related responses to caffeine in rats.

  1995cited by this paper
• Role of Phosphodiesterase III in the Antilipolytic Effect of Insulin in Vivo

  1995cited by this paper
• Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family).

  1995cited by this paper
• Effects of type‐selective phosphodiesterase inhibitors on glucose‐induced insulin secretion and islet phosphodiesterase activity

  1995cited by this paper
• Multiple cyclic nucleotide phosphodiesterases.

  1994cited by this paper
• Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

  1994cited by this paper
• The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors

  1991cited by this paper
• Control of insulin secretion: a model involving Ca2+, cAMP and diacylglycerol.

  1990cited by this paper
• Augmentation of glucose induced insulin secretion by pertussis vaccine, phentolamine and benextramine: involvement of mechanisms additional to prevention of the inhibitory actions of catecholamines in rats.

  1988cited by this paper
• Inhibition of Glucose‐induced Insulin Secretion by Calcium Channel Blocking Drugs In‐vitro but not In‐vivo in the Rat

  1988cited by this paper
• Theophylline prevents the inhibitory effect of prostaglandin E2 on glucose-induced insulin secretion in man.

  1988cited by this paper
• The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity.

  1987cited by this paper
• Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.

  1987cited by this paper
• Effects of theophylline and dibutyryl cyclic adenosine monophosphate on the membrane potential of mouse pancreatic beta‐cells.

  1984cited by this paper
• The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin.

  1984cited by this paper
• Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats

  1984cited by this paper
• Effect of Intravenous Aminophylline on Plasma Levels of Catecholamines and Related Cardiovascular and Metabolic Responses in Man

  1983cited by this paper
• Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes.

  1983cited by this paper
• Multiple cyclic nucleotide phosphodiesterase activities from rat brain.

  1971cited by this paper
• Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas

  1967cited by this paper

• A Review of Antidiabetic Medicinal Plants as a Novel Source of Phosphodiesterase Inhibitors: Future Perspective of New Challenges Against Diabetes Mellitus.

  2024cites this paper
• Effects of inhibition of phosphodiesterase 3B in pancreatic islets on insulin secretion: a potential link with some stimulatory pathways

  2019cites this paper
• A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases.

  2017cites this paper
• Cyclic nucleotide phosphodiesterase 3B is connected to osteopontin and protein kinase CK2 in pancreatic β-cells *

  2013cites this paper
• Cyclic nucleotide phosphodiesterase 3 B is connected to osteopontin and protein kinase CK 2 in pancreatic β-cells *

  2013cites this paper
• Differential Metabolic Effects of Novel Cilostamide Analogs, Methyl Carbostiryl Derivatives, on Mouse and Hyperglycemic Rat

  2012cites this paper
• The impact of glucotoxicity on pancreatic β-cell function

  2012cites this paper
• Original research article Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials ☆

  2010cites this paper
• cAMP/cGMP Dual-Specificity Phosphodiesterases

  2010cites this paper
• Expression and Regulation of Cyclic Nucleotide Phosphodiesterases in Human and Rat Pancreatic Islets

  2010influential citation
• Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets.

  2008cites this paper
• Hormonal regulation of phosphodiesterase 3B in adipocytes

  2007cites this paper
• Re-discovering PDE3 inhibitors--new opportunities for a long neglected target.

  2007cites this paper
• Beta-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin.

  2007cites this paper
• Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.

  2006cites this paper
• Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.

  2006cites this paper
• Modulation of cyclic nucleotides and cyclic nucleotide phosphodiesterases in pancreatic islet beta-cells and intestinal L-cells as targets for treating diabetes mellitus.

  2006cites this paper
• Phosphodiesterase 3B: An Important Regulator of Energy Homeostasis

  2006cites this paper
• Synergistic effect on insulin secretion from INS-1 cells of a sulfonylurea and a phosphodiesterase 3 inhibitor.

  2004cites this paper
• Targeting β‐cell cyclic 3′5′adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review

  2004cites this paper
• β-Cell-targeted Overexpression of Phosphodiesterase 3B in Mice Causes Impaired Insulin Secretion, Glucose Intolerance, and Deranged Islet Morphology*

  2004cites this paper
• The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation during gonadotropin-stimulated ovarian cycles in rhesus macaques.

  2004cites this paper
• Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice.

  2004cites this paper
• CHAPTER 194 – cAMP/cGMP Dual-Specificity Phosphodiesterases

  2003cites this paper
• Cyclic nucleotide phosphodiesterases in pancreatic islets

  2003cites this paper
• The Role of Phosphodiesterase 3B in the Regulation of Insulin Secretion

  2003cites this paper
• Important Role of Phosphodiesterase 3B for the Stimulatory Action of cAMP on Pancreatic β-Cell Exocytosis and Release of Insulin*

  2002cites this paper
• Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro.

  2002cites this paper
• Effect of type‐selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN‐BD11

  2000cites this paper
• The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesity

  1999cites this paper
• Isolation of human islets and beta-cells for pharmacological studies.

  1999cites this paper
• The Calcium/Calmodulin-dependent Phosphodiesterase PDE1C Down-regulates Glucose-induced Insulin Secretion*

  1999cites this paper